Galmed(GLMD)

财报披露

Galmed(GLMD)06-06 04:25

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-022747  Act: 34  Size: 171 KB 网页链接查看全文

财报披露

Galmed(GLMD)07-19 04:35

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-028342  Act: 34  Size: 16 KB 网页链接查看全文

财报披露

Galmed(GLMD)05-31 04:35

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-021989  Act: 34  Size: 239 KB 网页链接查看全文

财报披露

Galmed(GLMD)07-11 20:55

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-026889  Act: 34  Size: 16 KB 网页链接查看全文

美股妖股不靠谱2018-06-12 19:46

$Galmed Pharmaceuticals Ltd. - Ordinary Shares(GLMD)$ 有没有个位数买进的，我要拜师查看全文

美股妖股不靠谱2018-06-12 19:30

$Galmed Pharmaceuticals Ltd. - Ordinary Shares(GLMD)$ 牛逼查看全文

Yasoda2018-06-12 19:27

$Galmed Pharmaceuticals Ltd. - Ordinary Shares(GLMD)$ 起飞️查看全文

usbiostock2018-06-12 09:06

$Galmed Pharmaceuticals Ltd. - Ordinary Shares(GLMD)$ 公司将在美国东部时间上午8点召开会议，讨论Aramchol治疗非酒精性脂肪肝(NASH)临床2b期试验52周结果。查看全文

黑夜里的刀2016-04-07 11:28

$Galmed Pharmaceuticals(GLMD)$ --------买的最少的股 和 刚卖出的股 ，总是涨幅最大的股。呵呵，没有办法，听天由命吧。查看全文

Life-Struggle2016-03-19 12:13

$Galmed Pharmaceuticals(GLMD)$ 發財報(22-Mar)前出現甘大成交量及升幅...莫非查看全文

风信子木男2015-10-27 23:24

$Galmed Pharmaceuticals(GLMD)$这货近期明显有资金介入查看全文

风信子木男2015-10-20 12:04

$Galmed Pharmaceuticals(GLMD)$这货有长期走强的可能查看全文

Galmed Pharmaceuticals的评级信息汇总

深思远见2015-07-13 04:33

$Galmed Pharmaceuticals(GLMD)$近期评级信息如下：
20150709 Roth Capital 重申相同投资评价， 评级：买入， 目标价：$20.00
20150708 Maxim Group 重申相同投资评价， 评级：买入， 目标价：$24.00
更多分析和资讯，请关注微-信-公-众-号 stock_tong查看全文

Life-Struggle2014-10-13 22:49

$Galmed Pharmaceuticals(GLMD)$ 查看全文

财报披露

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-028342  Act: 34  Size: 16 KB 网页链接

财报披露

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-026889  Act: 34  Size: 16 KB 网页链接

财报披露

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-022747  Act: 34  Size: 171 KB 网页链接

财报披露

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-021989  Act: 34  Size: 239 KB 网页链接

年度财报

$Galmed(GLMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001493152-24-013203  Act: 34  Size: 9 MB 网页链接

财报披露

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010476  Act: 34  Size: 16 KB 网页链接

财报披露

$Galmed(GLMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-010019  Act: 34  Size: 32 KB 网页链接

超过5%股东持股披露「修订」

$Galmed(GLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023435  Act: 34  Size: 61 KB 网页链接

超过5%股东持股披露「修订」

$Galmed(GLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-000447  Act: 34  Size: 266 KB 网页链接

超过5%股东持股披露「修订」

$Galmed(GLMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-005902  Act: 34  Size: 97 KB 网页链接